Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Enzymatic determination of total serum cholesterol.

Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845 · see citing works

Detection of circulating tumor necrosis factor after endotoxin administration

Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · see citing works

Cachectin: More Than a Tumor Necrosis Factor

Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423 · see citing works

A colorimetric method for estimating serum triglycerides

Fletcher, M. J. (1968) · Clinica Chimica Acta · doi:10.1016/0009-8981(68)90041-7 · Cited by 1,138 · see citing works

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

Lähdevirta, J., Maury, C. P. J., Teppo, A., & Repo, H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90576-1 · Cited by 717 · see citing works

Tumour necrosis factors α and β inhibit virus replication and synergize with interferons

Wong, G. H., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 707 · see citing works

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

Schüpbach, J., Popovič, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610 · see citing works

Cytokine appearance in human endotoxemia and primate bacteremia.

HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532 · see citing works

The Acquired Immunodeficiency Syndrome

Gottlieb, M. S., Groopman, J. E., WEINSTEIN, W. M., FAHEY, J. L., & DETELS, R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-208 · Cited by 471 · see citing works

Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon

Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 458 · see citing works

Hypertriglyceridemia in the acquired immunodeficiency syndrome

Grünfeld, C., Kotler, D. P., Hamadeh, R., Tierney, A. R., Wang, J., & Pierson, R. N. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90225-8 · Cited by 436 · see citing works

Body composition studies in patients with the acquired immunodeficiency syndrome

Dp, K., Wang, J., & Pierson, R. (1985) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/42.6.1255 · Cited by 411 · see citing works

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

Feingold, K. R., & Grünfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403 · see citing works

Serum Lipids in Infection

Gallin, J. I., Kaye, D., & O’Leary, W. M. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911132812001 · Cited by 375 · see citing works

Immunopathogenesis of the Acquired Immunodeficiency Syndrome

Bowen, D. L., LANE, H. C., & Fauci, A. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-704 · Cited by 328 · see citing works

Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines

Poli, G., Orenstein, J. M., Kinter, A. L., Folks, T. M., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2470148 · Cited by 326 · see citing works

Acid-Labile Human Leukocyte Interferon in Homosexual Men with Kaposi's Sarcoma and Lymphadenopathy

DeStefano, E., Friedman, R. M., Friedman‐Kien, A. E., Goedert, J. J., Henriksen-DeStefano, D., Preble, O. T., SONNABEND, J. A., & Vilček, J. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.4.451 · Cited by 326 · see citing works

RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO

Ho, D. D., Rota, T. R., Kaplan, J. C., Hartshorn, K. L., Andrews, C., Schooley, R. T., & Hirsch, M. S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305 · see citing works

Metabolic Response to Infection

Beisel, W. R. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.000301 · Cited by 300 · see citing works

Lipids, lipoproteins, and apoproteins in serum during infection.

Alvarez, C., & Ramos, A. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.1.142 · Cited by 285 · see citing works

Changes in serum lipoprotein pattern induced by acute infections

Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkilä, E. A., & Taskinen, M. (1988) · Metabolism · doi:10.1016/0026-0495(88)90120-5 · Cited by 275 · see citing works

Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal

Rouzer, C. A., & Cerami, A. (1980) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(80)90046-8 · Cited by 261 · see citing works

ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA

Lane, H. C., Feinberg, J., Davey, V. J., Deyton, L., Baseler, M., Manischewitz, J. F., Masur, H., Kovacs, J. A., Herpin, B. R., WALKER, R. E., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90811-2 · Cited by 259 · see citing works

Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.

Beutler, B., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3969 · Cited by 235 · see citing works

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon

Hartshorn, K. L., Vogt, M. W., Chou, T., Blumberg, R. S., Byington, R. E., Schooley, R. T., & Hirsch, M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.168 · Cited by 234 · see citing works

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

Sherman, M. L., Spriggs, D. R., Arthur, K. A., Imamura, K., Frei, E., & Kufe, D. W. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.344 · Cited by 215 · see citing works

SEPTICÆMIA DUE TO PORCINE STREPTOCOCCI

Kloppenburg, M., Mulder, N. H., & Houwerzijl, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92719-1 · Cited by 212 · see citing works

Multiple Cytokines Stimulate Hepatic Lipid Synthesisin Vivo*

FEINGOLD, K. R., Soued, M., Serio, M., MOSER, A. H., Dinarello, C. A., & Grünfeld, C. (1989) · Endocrinology · doi:10.1210/endo-125-1-267 · Cited by 210 · see citing works

Acid-Labile Alpha Interferon

Eyster, M. E., Goedert, J. J., Poon, M. C., & Preble, O. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309083091003 · Cited by 201 · see citing works

Combined Zidovudine and Interferon-α Therapy in Patients with Kaposi Sarcoma and the Acquired Immunodeficiency Syndrome (AIDS)

Kovacs, J. A., Deyton, L., Davey, R., Falloon, J., Zunich, K., Lee, D., Metcalf, J. A., Bigley, J. W., Sawyer, L. A., Zoon, K. C., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-280 · Cited by 190 · see citing works

CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMA

de Wit, R., Boucher, C., Veenhof, K. H. N., Schattenkerk, J. K. M. E., Bakker, P., & Sa, D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90810-0 · Cited by 185 · see citing works

Total-body potassium in health: effects of age, sex, height, and fat

Pierson, R., Lin, D., & Phillips, R. H. (1974) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1974.226.1.206 · Cited by 171 · see citing works

Commentary from Westminster

Deitch, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92858-1 · Cited by 124 · see citing works

Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes.

Keay, S. K., & Grossberg, S. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4099 · Cited by 123 · see citing works

Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: Relationship with control

Lopes-Virella, M. F., Wohltmann, H. J., LOADHOLT, C. B., & Buse, M. G. (1981) · Diabetologia · doi:10.1007/bf00252657 · Cited by 119 · see citing works

The role of tumor necrosis factor (cachectin) in cachexia

Oliff, A. (1988) · Cell · doi:10.1016/0092-8674(88)90543-0 · Cited by 115 · see citing works

Hypertriglyceridemia Produced by Endotoxin: Role of Impaired Triglyceride Disposal Mechanisms

Kaufmann, R. L., Matson, C. F., & Beisel, W. R. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.5.548 · Cited by 114 · see citing works

Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion

Wolfe, R. R., Shaw, J. H., & Durkot, M. J. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.6.e732 · Cited by 112 · see citing works

Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations.

Reddy, M. M., Sorrell, S., Lange, M., & Grieco, M. H. (1988) · PubMed · Cited by 109 · see citing works

LOW-DOSE ASPIRIN AND TWIN PREGNANCY

Trudinger, B. J., Cook, C., Giles, W. B., Connelly, A., & Thompson, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91815-1 · Cited by 96 · see citing works

Infection with Diplococcus pneumoniae and Salmonella typhimurium in Monkeys: Changes in Plasma Lipids and Lipoproteins

Fiser, R. H., Denniston, J. C., & Beisel, W. R. (1972) · The Journal of Infectious Diseases · doi:10.1093/infdis/125.1.54 · Cited by 88 · see citing works

Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1

Price, S. R., Mizel, S. B., & Pekala, P. H. (1986) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(86)90201-6 · Cited by 85 · see citing works

Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism

Lees, R. S., Fiser, R. H., Beisel, W. R., & Bartelloni, P. J. (1972) · Metabolism · doi:10.1016/0026-0495(72)90005-4 · Cited by 74 · see citing works

Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.

Grünfeld, C., Wilking, H., Neese, R. A., Gavin, L. A., Moser, A. H., Gulli, R., Serio, M., & Feingold, K. R. (1989) · PubMed · Cited by 68 · see citing works

Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases.

Ehnholm, C., Aho, K., Huttunen, J. K., Kostiainen, E., Mattila, K. J., Pakkarainen, J., & Cantell, K. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.2.1.68 · Cited by 60 · see citing works

Role of Metabolism in Pathogenesis of Bacteremia Due to Diplococcus pneumoniae in Rabbits

GUCKIAN, J. C. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/127.1.1 · Cited by 49 · see citing works

Long-term Follow-up of Serum-interferon and Its Acid-stability in a Group of Homosexual Men

Buimovici‐Klein, E., Lange, M., Klein, R. J., Grieco, M. H., & Cooper, L. Z. (1986) · Aids Research · doi:10.1089/aid.1.1986.2.99 · Cited by 42 · see citing works

Relationships Between Control and Serum Lipids in Juvenile-onset Diabetes

Glasgow, A. M., August, G. P., & Hung, W. (1981) · Diabetes Care · doi:10.2337/diacare.4.1.76 · Cited by 40 · see citing works

Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons

Dixon, R. M., Borden, E. C., Keim, N. L., Anderson, S., Spennetta, T. L., Tormey, D. C., & Shrago, E. S. (1984) · Metabolism · doi:10.1016/0026-0495(84)90136-7 · Cited by 37 · see citing works

Effects of Recombinant Interferon-α 2 Treatment upon Lipid Concentrations and Lipoprotein Composition

Massaro, E. R., Borden, E. C., Hawkins, M., Wiebe, D. A., & Shrago, E. S. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.655 · Cited by 36 · see citing works

Plasma Lipids and Microangiopathy in Insulin-dependent Diabetes Mellitus

Eckel, R. H., Mclean, E., Albers, J. J., Cheung, M. C., & Bierman, E. L. (1981) · Diabetes Care · doi:10.2337/diacare.4.4.447 · Cited by 34 · see citing works

Serum Lipids in Viral and Bacterial Meningitis

Kerttula, Y., & WEBER, T. H. (1986) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548609032329 · Cited by 32 · see citing works

Dyslipoproteinemia in Patients with Severe Bacterial Infections

Åkerlund, B., Carlson, L. A., & Jarstrand, C. (1986) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548609021659 · Cited by 32 · see citing works

Testing for antibodies to AIDS‐associated retrovirus (HTLV‐III/LAV) by indirect fixed cell immunofluorescence: Specificity, sensitivity, and applications

Hedenskog, M., Dewhurst, S., Ludvigsen, C., Sinangil, F., Rodriguez, L., Wu, Y., & Volsky, D. J. (1986) · Journal of Medical Virology · doi:10.1002/jmv.1890190405 · Cited by 26 · see citing works

Hyperglycemia and Plasma Lipid Levels: Covariations in Insulin-dependent Diabetes

Sosenko, J. M., Breslow, J. L., Miettinen, O. S., & Gabbay, K. H. (1982) · Diabetes Care · doi:10.2337/diacare.5.1.40 · Cited by 26 · see citing works

Interferon production in male homosexuals with the acquired immune deficiency syndrome (AIDS) or generalized lymphadenopathy

Abb, J., Deinhardt, F. W., & Kochen, M. M. (1984) · Infection · doi:10.1007/bf01645949 · Cited by 25 · see citing works

Activated interferon system in healthy homosexual men

Levin, S., Hahn, T., Handzel, Z. T., Galili-Wiesstub, E., Bregman, V., Myer, R., Tinowitz, M., Altman, Y., Barzilai, N., Brenner, Y., et al. (1985) · Antiviral Research · doi:10.1016/0166-3542(85)90027-0 · Cited by 12 · see citing works

Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes

(1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6941-d · Cited by 12 · see citing works

How Much Can We Know About Acute Pancreatitis?

Spechler, S. J. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-5-704 · Cited by 12 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Grünfeld, C., Pang, M., Doerrler, W. T., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1373735 · Cited by 845 · see citing works

Impact of HIV infection and HAART on serum lipids in men

Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624 · see citing works

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D. L., & Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 576 · see citing works

Inflammation and cardiovascular disease: From mechanisms to therapeutics

Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473 · see citing works

Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins

Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403 · see citing works

Metabolic Disturbances and Wasting in the Acquired Immunodeficiency Syndrome

Flier, J. S., Underhill, L. H., Grunfeld, C., & Feingold, K. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270506 · Cited by 398 · see citing works

Energy Expenditure and Wasting in Human Immunodeficiency Virus Infection

Macallan, D. C., Noble, C., Baldwin, C., Jebb, S. A., Prentice, A. M., Coward, W. A., Sawyer, M. B., McManus, T. J., & Griffin, G. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330202 · Cited by 391 · see citing works

Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

Hellerstein, M. K., Christiansen, M., Kaempfer, S., Kletke, C., Wu, K. K., Reid, J., Mulligan, K. M., Hellerstein, N. S., & Shackleton, C. H. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115206 · Cited by 362 · see citing works

Fat distribution and metabolic changes in patients with HIV infection

Safrin, S., & Grünfeld, C. (1999) · AIDS · doi:10.1097/00002030-199912240-00002 · Cited by 358 · see citing works

LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.

Feingold, K. R., Grünfeld, C., Pang, M., Doerrler, W. T., & Krauss, R. M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.12.1496 · Cited by 302 · see citing works

Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Grünfeld, C., Pang, M., Shimizu, L., Shigenaga, J. K., Jensen, P., & Kr, F. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.455 · Cited by 278 · see citing works

Blood‐brain barrier abnormalities in acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain

Petito, C. K., & Cash, K. S. (1992) · Annals of Neurology · doi:10.1002/ana.410320509 · Cited by 276 · see citing works

Clinical Toxicity of the Interferons

Vial, T., & Descotes, J. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00003 · Cited by 267 · see citing works

Increased de novo hepatic lipogenesis in human immunodeficiency virus infection

Hellerstein, M. K., Grünfeld, C., Wu, K. K.-Y., Christiansen, M., Kaempfer, S., Kletke, C., & Shackleton, C. H. L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445011 · Cited by 242 · see citing works

State of the Science Conference

Grinspoon, S. K., Grünfeld, C., Kotler, D. P., Currier, J. S., Lundgren, J. D., Dubé, M. P., Lipshultz, S. E., Hsue, P. Y., Squires, K., Schambelan, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189622 · Cited by 230 · see citing works

Endocrine and Metabolic Disturbances in Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome*

Sellmeyer, D. E., & Grünfeld, C. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-518 · Cited by 227 · see citing works

HIV Disease and the Endocrine System

Desforges, J. F., Grinspoon, S. K., & Bilezikian, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271906 · Cited by 226 · see citing works

Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection

Shor‐Posner, G., Basit, A., Lü, Y., Cabrejos, C., Chang, J., Fletcher, M., Mantero-Atienza, E., & Baum, M. K. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90087-6 · Cited by 197 · see citing works

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Mayer, K. H., Dubé, M. P., Sprecher, D. L., Henry, W. K., Aberg, J. A., Torriani, F. J., Hodis, H. N., Schouten, J., Levin, J., Myers, G. L., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317429 · Cited by 196 · see citing works

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

Wand, H. C., Calmy, A., Carey, D., Samaras, K., Carr, A. D., Law, M. G., Cooper, D. A., & Emery, S. (2007) · AIDS · doi:10.1097/qad.0b013e3282efad32 · Cited by 196 · see citing works

The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.

Kr, F., Krauss, R. M., Pang, M., Doerrler, W. T., Jensen, P. B., & Grünfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 182 · see citing works

HIV–Associated Lipodystrophy: Pathogenesis, Prognosis, Treatment, and Controversies

Koutkia, P., & Grinspoon, S. K. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104412 · Cited by 179 · see citing works

Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors

Grünfeld, C., Kotler, D. P., Arnett, D. K., Falutz, J., Haffner, S. M., Hruz, P. W., Masur, H., Meigs, J. B., Mulligan, K. M., Reiss, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189623 · Cited by 178 · see citing works

Incidence of Metabolic Syndrome in a Cohort of HIV-Infected Adults and Prevalence Relative to the US Population (National Health and Nutrition Examination Survey)

Jacobson, D. L., Tang, A., Spiegelman, D. L., Thomas, A. M., Skinner, S. C., Gorbach, S. L., & WANKE, C. A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000243093.34652.41 · Cited by 175 · see citing works

HIV and HAART-Associated Dyslipidemia

Feeney, E. R., & Mallon, P. W. G. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010049 · Cited by 173 · see citing works

Plasma lipids in HIV‐infected patients: a prospective study in 95 patients

Constans, J., Pellegrin, J., Peuchant, E., Dumon, M. F., Pellegrin, I., Sergeant, C., Simonoff, M., Brossard, G., Barbeau, P., Fleury, H. J., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02185.x · Cited by 172 · see citing works

Immunogenicity of aggregates of recombinant human growth hormone in mouse models

Fradkin, A. H., Carpenter, J. F., & Randolph, T. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21834 · Cited by 170 · see citing works

Cutaneous findings in HIV-1-positive patients: A 42-month prospective study

Smith, K. J., Skelton, H. G., Yeager, J. K., Ledsky, R., McCarthy, W., BAXTER, D. L., & Wagner, K. F. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70236-5 · Cited by 162 · see citing works

Metabolic complications associated with antiretroviral therapy

Jain, R. G., Furfine, E. S., Pedneault, L., White, A. J., & Lenhard, J. M. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00148-6 · Cited by 150 · see citing works

Changes in the concentration and composition of plasma lipoproteins during the acute phase response

Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148 · see citing works

Blood Lipid Measurements

Cooper, G. R. (1992) · JAMA · doi:10.1001/jama.1992.03480120090039 · Cited by 141 · see citing works

Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms

Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Cytokine · doi:10.1016/1043-4666(94)90074-4 · Cited by 137 · see citing works

HIV-associated dyslipidaemia: pathogenesis and treatment

Oh, J., & Hegele, R. A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70287-6 · Cited by 137 · see citing works

Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

Obare, L. M., Temu, T. M., Mallal, S. A., & Wanjalla, C. N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323891 · Cited by 147 · see citing works

Adipocytes Targets and Actors in the Pathogenesis of HIV-Associated Lipodystrophy and Metabolic Alterations

Gougeon, M., Pénicaud, L., Fromenty, B., Leclercq, P., Viard, J., & Capeau, J. (2004) · Antiviral Therapy · doi:10.1177/135965350400900206 · Cited by 129 · see citing works

HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients

Kotler, D. P. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318186519c · Cited by 128 · see citing works

Hyperlipidemia Associated with HIV Protease Inhibitor Use: Pathophysiology, Prevalence, Risk Factors and Treatment

Penzak, S. K. C. S. R. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655400750045196 · Cited by 123 · see citing works

Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection

Macallan, D. C., McNurlan, M. A., Milne, E., Calder, A. G., Garlick, P. J., & Griffin, G. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.818 · Cited by 117 · see citing works

Lipodystrophy Syndrome in HIV Infection

Behrens, G. M. N., Stoll, M., & Schmidt, R. E. (2000) · Drug Safety · doi:10.2165/00002018-200023010-00004 · Cited by 107 · see citing works

Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy

Shevitz, A., Knox, T. A., Spiegelman, D. L., Roubenoff, R., Gorbach, S. L., & Skolnik, P. R. (1999) · AIDS · doi:10.1097/00002030-199907300-00012 · Cited by 102 · see citing works

The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications

Flint, O. P., Noor, M. A., Hruz, P. W., Hylemon, P. B., Yarasheski, K. E., Kotler, D. P., Parker, R. A., & Bellamine, A. (2009) · Toxicologic Pathology · doi:10.1177/0192623308327119 · Cited by 101 · see citing works

Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex

Mildvan, D., Wilets, I. F., Machado, S. G., & Grossberg, S. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)91058-g · Cited by 101 · see citing works

Longitudinal changes in serum lipids among HIV‐infected men on highly active antiretroviral therapy

Riddler, S., Li, X., Chu, H., Kingsley, L., Dobs, A. S., Evans, R., Palella, F. J., Visscher, B. R., Chmiel, J. S., & Sharrett, A. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00470.x · Cited by 99 · see citing works

Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study

Madeddu, G., Spanu, A., Chessa, F., Calia, G. M., Lovigu, C., Solinas, P., Mannazzu, M., Falchi, A., Mura, M. S., & Madeddu, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02472.x · Cited by 97 · see citing works

Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1β- and Tumor Necrosis Factor-α-induced Low Density Lipoprotein Receptor Expression in HepG2 Cells

Kumar, A., Middleton, A., Chambers, T. C., & Mehta, K. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15742 · Cited by 97 · see citing works

Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review

Souza, S. J., Luzia, L. A., dos Santos, S. D. S., & Rondó, P. H. D. C. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2012.11.003 · Cited by 93 · see citing works

Blood lipids of patients with chronic hepatitis: differences related to viral etiology

Fabris, C., Federico, E., Soardo, G., Falleti, E., & Pirisi, M. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06532-7 · Cited by 88 · see citing works

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

Calza, L., Manfredi, R., & Chiodo, F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00115-8 · Cited by 83 · see citing works

Hypofibrinolytic State in HIV-1–Infected Patients Treated With Protease Inhibitor–Containing Highly Active Antiretroviral Therapy

Koppel, K., Bratt, G., Schulman, S., Bylund, H., & Sandström, E. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00003 · Cited by 83 · see citing works

Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management

Gutierrez, A., & Balasubramanyam, A. (2011) · Endocrine · doi:10.1007/s12020-011-9565-z · Cited by 82 · see citing works

Seborrhoeic dermatitis is not caused by an altered immune response to<i>Malassezia</i>yeast: MALASSEZIA IMMUNITY IN SEBORRHOEIC DERMATITIS

Parry, & Sharpe (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02362.x · Cited by 82 · see citing works

Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men

Corssmit, E. P. M., Heyligenberg, R., Endert, E., Sauerwein, H. P., & Romijn, J. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593416 · Cited by 82 · see citing works

Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients

Asztalos, B. F., Schaefer, E. J., Horvath, K. V., Cox, C. E., Skinner, S. C., Gerrior, J., Gorbach, S. L., & WANKE, C. A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.013 · Cited by 81 · see citing works

Cardiovascular disease in HIV-positive patients

Kamin, D., & Grinspoon, S. K. (2005) · AIDS · doi:10.1097/01.aids.0000166087.08822.bc · Cited by 81 · see citing works

The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

Marley, S. B., Deininger, M. W., Davidson, R. J., Goldman, J. M., & Gordon, M. Y. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00142-9 · Cited by 79 · see citing works

Antiretroviral Therapy is Associated With an Atherogenic Lipoprotein Phenotype Among HIV-1-Infected Men in the Multicenter AIDS Cohort Study

Riddler, S. A., Li, X., Otvos, J. D., Post, W. S., Palella, F. J., Kingsley, L., Visscher, B. R., Jacobson, L. P., & Sharrett, A. R. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817bbbf0 · Cited by 78 · see citing works

Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine Production

Hellerstein, M. K., Wu, K. K., McGrath, M. S., Faix, D. J., George, D., Shackleton, C. H. L., Horn, W. F., Hoh, R., & Neese, R. A. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199603010-00006 · Cited by 78 · see citing works

Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment

Killian, M. S., Fujimura, S. H., Hecht, F. M., & Levy, J. A. (2006) · AIDS · doi:10.1097/01.aids.0000232231.34253.bd · Cited by 77 · see citing works

Interferons in the pathogenesis and treatment of human immunodeficiency virus infection

Poli, G., Biswas, P., & Fauci, A. S. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90069-8 · Cited by 78 · see citing works

MALNUTRITION IN HIV INFECTION

Babameto, G. P., & Kotler, D. P. (1997) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70301-0 · Cited by 74 · see citing works

Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART

Calza, L., Manfredi, R., & Chiodo, F. (2002) · Infection · doi:10.1007/s15010-001-2052-3 · Cited by 72 · see citing works

Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes

Marshall, M. K., Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Endocrinology · doi:10.1210/en.135.1.141 · Cited by 72 · see citing works

Hyperlipidemia Associated with Protease Inhibitor Therapy

Echevarria, K. L., Hardin, T. C., & Smith, J. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18174 · Cited by 72 · see citing works

The Role of the Cytokines, Interferon Alpha and Tumor Necrosis Factor in the Hypertriglyceridemia and Wasting of AIDS ,

Grünfeld, C., & Feingold, K. R. (1992) · Journal of Nutrition · doi:10.1093/jn/122.suppl_3.749 · Cited by 71 · see citing works

Effects of interferon-alpha (IFN-α) administration on leucocytes in healthy humans

Corssmit, E. P. M., Heijligenberg, R., Hack, C. E., Endert, E., Sauerwein, H. P., & Romijn, J. A. (1997) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1997.269-ce1161.x · Cited by 70 · see citing works

Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients

Dave, J. A., Levitt, N. S., Ross, I. L., Lacerda, M., Maartens, G., & Blom, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151911 · Cited by 69 · see citing works

Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

Gordon, M. Y., Marley, S. B., Lewis, J. L., Davidson, R. J., Nguyen, D., Grand, F. H., Amos, T. A. S., & Goldman, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3094 · Cited by 68 · see citing works

Pathogenesis of Psoriasis: Current Concepts

Kadunce, D. P., & Krueger, G. G. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30037-8 · Cited by 66 · see citing works

Postsurgical reduction of serum lipoproteins: Interleukin-6 and the acute-phase response

Akgün, S., Ertel, N. H., Mosenthal, A. C., & Oser, W. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90083-x · Cited by 65 · see citing works

Stimulation of vitamin A1 acid signaling by the HIV protease inhibitor indinavir

Lenhard, J. M., Weiel, J. E., Paulik, M. A., & Furfine, E. S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00246-x · Cited by 65 · see citing works

Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy

Schmitz, M., Michl, G. M., Walli, R., Bogner, J. R., Bedynek, A., Seidel, D., Goebel, F. D., & Demant, T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103010-00004 · Cited by 64 · see citing works

Enhancement of tissue glutathione for antioxidant and immune functions in malnutrition

Bray, T. Μ., & Taylor, C. G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90246-1 · Cited by 61 · see citing works

Nutrition and HIV infection

Salomon, J., de Truchis, P., & Melchior, J. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2001464 · Cited by 60 · see citing works

An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line

Sipe, K. J., Srisawasdi, D., Dantzer, R., Kelley, K. W., & Weyhenmeyer, J. A. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00310-o · Cited by 58 · see citing works

Biologic Responses to IFN-α Administration in Humans

Corssmit, E. P. M., de Metz, J., Sauerwein, H. P., & Romijn, J. A. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000750053690 · Cited by 57 · see citing works

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

Titanji, B. K., Gavegnano, C., Hsue, P. Y., Schinazi, R. F., & Marconi, V. C. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014873 · Cited by 56 · see citing works

Safety and Efficacy of Extended-Release Niacin for the Treatment of Dyslipidaemia in Patients with HIV Infection: Aids Clinical Trials Group Study A5148

Meixner, L., Hoffman, J., Zwickl, B., Goldman, M. H., Whitely, K., Conrad, A., Fichtenbaum, C. J., Hyc, F., Spitz, T., Shaw, D. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100802 · Cited by 55 · see citing works

NUTRITIONAL ASPECTS OF HIV INFECTION

Nerad, J. L., & Gorbach, S. L. (1994) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30603-6 · Cited by 55 · see citing works

Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals

Carpentier, A. C., Patterson, B. W., Uffelman, K. D., Salit, I. E., & Lewis, G. F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.035 · Cited by 54 · see citing works

Lipid Metabolism in Treated HIV Infection

Dubé, M. P., & Cadden, J. J. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.04.004 · Cited by 53 · see citing works

Tumor necrosis factor, cytokines, and the hyperlipidemia of infection

Grünfeld, C., & Feingold, K. R. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(91)90027-k · Cited by 51 · see citing works

Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998

Thiébaut, R., Dabis, F., Malvy, D. J.-M., Jacqmin‐Gadda, H., Mercié, P., & Valentin, V. D. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200003010-00009 · Cited by 52 · see citing works

Nutritional and hormonal regulation of glutathione homeostasis

Taylor, C. G., Nagy, L. E., & Bray, T. Μ. (1996) · Current topics in cellular regulation · doi:10.1016/s0070-2137(96)80007-0 · Cited by 52 · see citing works

Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50 · see citing works

Interactions Between Nutrition and Infection with Human Immunodeficiency Virus

Gorbach, S. L., Knox, T. A., & Roubenoff, R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1993.tb03110.x · Cited by 50 · see citing works

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

Fernández‐Miranda, C., Pulido, F., Carrillo, J. L., Larumbe, S., Gómez‐Izquierdo, T., Ortuño, B., Rubio, R., & del Palacio, A. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00050-3 · Cited by 49 · see citing works

The effects of HIV protease inhibitors on carbohydrate and lipid metabolism

Lee, G. A., Rao, M. N., & Grünfeld, C. (2005) · Current HIV/AIDS Reports · doi:10.1007/s11904-996-0008-z · Cited by 49 · see citing works

Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree

Newman, D. L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg012 · Cited by 47 · see citing works

Management of Protease Inhibitor-Associated Hyperlipidemia

Penzak, S. R., & Chuck, S. K. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202020-00003 · Cited by 46 · see citing works

Endocrine and metabolic effects of interferon-alpha in humans

Corssmit, E. P. M., Heijligenberg, R., Endert, E., Ackermans, M. T., Sauerwein, H. P., & Romijn, J. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784081 · Cited by 46 · see citing works

Amprenavir

Noble, S., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060060-00012 · Cited by 46 · see citing works

Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria

Mbunkah, H. A., Meriki, H. D., Kukwah, A. T., Nlinwe, N. O., & Nkuo-Akenji, T. K. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-92 · Cited by 45 · see citing works

The acute‐phase response and associated lipoprotein abnormalities accompanying lymphoma

Blackman, J. D., Cabana, V. G., & Mazzone, T. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00674.x · Cited by 45 · see citing works

Dyslipidemia in an HIV-Positive Antiretroviral Treatment-Naive Population in Dar es Salaam, Tanzania

Armstrong, C. A., Liu, E., Okuma, J. O., Spiegelman, D. L., Guerino, C., Njelekela, M. A., Grinspoon, S., Fawzi, W. W., & Hawkins, C. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318219a3d1 · Cited by 44 · see citing works

Cardiovascular Complications of HIV in Endemic Countries

Feinstein, M. J., Bogorodskaya, M., Bloomfield, G. S., Vedanthan, R., Siedner, M. J., Kwan, G. F., & Longenecker, C. T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0794-x · Cited by 44 · see citing works

Serum amyloid A and high‐density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders

Salazar, A., Pintó, X., & Mañá, J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00913.x · Cited by 44 · see citing works

Dietary Fish Oil and Cytokine and Eicosanoid Production During Human Immunodeficiency Virus Infection

Bell, S. J., Chavali, S. R., Bistrian, B. R., Connolly, C. A., Utsunomiya, T., & Forse, R. A. (1996) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719602000143 · Cited by 44 · see citing works

Endocrinological aspects of HIV infection

Mirza, F., Luthra, P., & Chirch, L. M. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0812-x · Cited by 44 · see citing works

Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy

Calza, L., Manfredi, R., & Chiodo, F. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.241 · Cited by 42 · see citing works

The Role of the Cytokines, Interferon Alpha and Tumor Necrosis Factor in the Hypertriglyceridemia and Wasting of AIDS ,

Grünfeld, C., & Feingold, K. R. (1992) · Journal of Nutrition · doi:10.1093/jn/122.suppl_3.749 · Cited by 71 · see citing works

Hypertriglyceridemia in the acquired immunodeficiency syndrome

Grünfeld, C., Kotler, D. P., Hamadeh, R., Tierney, A. R., Wang, J., & Pierson, R. N. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90225-8 · Cited by 436 · see citing works

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Grünfeld, C., Pang, M., Doerrler, W. T., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1373735 · Cited by 845 · see citing works

Increased serum interferon alpha in HIV–1 associated lipodystrophy syndrome

Christeff, N., Melchior, J., de Truchis, P., Perronne, C., & Gougeon, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.0014-2972.2001.00940.x · Cited by 58 · see citing works

Interféron et facteur de nécrose tumorale sériques chez 95 patients infectés par le VIH

Constans, J., Pellegrin, J., Pellegrin, I., Peuchant, E., Dumon, M. F., Sergeant, C., Simonoff, M., Brossard, G., Barbeau, P., Clerc, M., et al. (1993) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)80122-5 · Cited by 1 · see citing works